lysyl-aspartyl-glutamyl-leucine has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, F; Li, QJ; Yang, XC; Yin, R; Zheng, W; Zhong, BY | 1 |
| Chang, MC; Chen, CA; Cheng, WF; Hsieh, CY; Lee, CN; Liao, CW; Su, YN; Syu, MH | 1 |
2 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Experimental Neoplasms
| Article | Year |
|---|---|
HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
Topics: Animals; Cancer Vaccines; Cell Line, Transformed; Dendritic Cells; Drug Design; Female; HLA-A2 Antigen; Immunity, Cellular; Immunotherapy, Adoptive; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oligopeptides; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Papillomavirus Vaccines; Protein Sorting Signals; T-Lymphocytes, Cytotoxic; Th1 Cells; Time Factors | 2009 |
Fusion protein vaccine by domains of bacterial exotoxin linked with a tumor antigen generates potent immunologic responses and antitumor effects.
Topics: ADP Ribose Transferases; Animals; Bacterial Toxins; Cancer Vaccines; CD8-Positive T-Lymphocytes; Epitopes, T-Lymphocyte; Exotoxins; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Oligopeptides; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Protein Sorting Signals; Protein Structure, Tertiary; Pseudomonas aeruginosa Exotoxin A; Recombinant Fusion Proteins; Vaccines, Synthetic; Virulence Factors | 2005 |